Literature DB >> 17628392

Heritability and segregation analysis of osteosarcoma in the Scottish deerhound.

Jeffrey C Phillips1, Betty Stephenson, Marlene Hauck, John Dillberger.   

Abstract

Osteosarcoma is the most common malignant bone tumor in dogs and, like its human orthologue, is characterized by aggressive local behavior and high metastatic rates. The Scottish deerhound is a breed of dog with a >15% incidence of osteosarcoma and represents an excellent spontaneously occurring large-animal model of the human disease. We modeled the transmission of the osteosarcoma phenotype in a population of over 1000 related deerhounds ascertained as part of a prospective health study. Variance component analysis, segregation analysis, and linear modeling were performed to evaluate heritability, to infer the presumptive transmission model, and to identify covariate effects for this phenotype within the breed, respectively. Based on variance component analysis, heritability (h2) was estimated to be 0.69. Six transmission models were analyzed by segregation analysis; based on Akaike's information criteria, the most parsimonious model was the Mendelian major gene model with dominant expression. Linear modeling identified gender and genotype as significant predictors of disease outcome. Importantly, duration of gonadal hormone exposure, weight, and height at maturity were not significant predictors of outcome. Inheritance of the putative high-risk allele was thus associated with >75% risk of disease occurrence compared to the <5% baseline risk. These results support the hypothesis that a major gene with a dominant effect explains most of the osteosarcoma phenotype within the Scottish deerhound.

Entities:  

Mesh:

Year:  2007        PMID: 17628392     DOI: 10.1016/j.ygeno.2007.05.001

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  14 in total

1.  Increased risk of cancer in dogs and humans: a consequence of recent extension of lifespan beyond evolutionarily-determined limitations?

Authors:  Aaron L Sarver; Kelly M Makielski; Taylor A DePauw; Ashley J Schulte; Jaime F Modiano
Journal:  Aging Cancer       Date:  2022-02-23

Review 2.  Canine and murine models of osteosarcoma.

Authors:  Jessica Beck; Ling Ren; Shan Huang; Erika Berger; Kathleen Bardales; Joshua Mannheimer; Christina Mazcko; Amy LeBlanc
Journal:  Vet Pathol       Date:  2022-03-26       Impact factor: 3.157

Review 3.  Domestic dogs and cancer research: a breed-based genomics approach.

Authors:  Brian W Davis; Elaine A Ostrander
Journal:  ILAR J       Date:  2014

Review 4.  Leading the way: canine models of genomics and disease.

Authors:  Abigail L Shearin; Elaine A Ostrander
Journal:  Dis Model Mech       Date:  2010 Jan-Feb       Impact factor: 5.758

5.  Influence of genetic background on tumor karyotypes: evidence for breed-associated cytogenetic aberrations in canine appendicular osteosarcoma.

Authors:  Jaime F Modiano; Matthew Breen; Rachael Thomas; Huixia J Wang; Pei-Chien Tsai; Cordelia F Langford; Susan P Fosmire; Cristan M Jubala; David M Getzy; Gary R Cutter
Journal:  Chromosome Res       Date:  2009-04-01       Impact factor: 5.239

6.  Osteosarcoma inheritance in two families of Scottish deerhounds.

Authors:  John E Dillberger; Sara Ann McAtee
Journal:  Canine Genet Epidemiol       Date:  2017-03-17

Review 7.  Comparative review of human and canine osteosarcoma: morphology, epidemiology, prognosis, treatment and genetics.

Authors:  Siobhan Simpson; Mark David Dunning; Simone de Brot; Llorenç Grau-Roma; Nigel Patrick Mongan; Catrin Sian Rutland
Journal:  Acta Vet Scand       Date:  2017-10-24       Impact factor: 1.695

Review 8.  Comparative Aspects of Osteosarcoma Pathogenesis in Humans and Dogs.

Authors:  Timothy M Fan; Chand Khanna
Journal:  Vet Sci       Date:  2015-08-17

9.  Breed-predispositions to cancer in pedigree dogs.

Authors:  Jane M Dobson
Journal:  ISRN Vet Sci       Date:  2013-01-17

10.  Arginase treatment prevents the recovery of canine lymphoma and osteosarcoma cells resistant to the toxic effects of prolonged arginine deprivation.

Authors:  James W Wells; Christopher H Evans; Milcah C Scott; Barbara C Rütgen; Timothy D O'Brien; Jaime F Modiano; Goran Cvetkovic; Slobodan Tepic
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.